Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023
Overview
World Vaccine Congress West Coast
Stock Information
Nasdaq:
COCPPrice

Change

Mkt Cap

Volume



Company Overview
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. We employ unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. These technologies are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer. We have identified promising preclinical and early clinical stage antiviral therapeutics that target the replication process of influenza virus, SARS-CoV-2 virus, hepatitis C virus, and norovirus.